Compare BIO & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KBR |
|---|---|---|
| Founded | 1952 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.3B |
| IPO Year | N/A | 2006 |
| Metric | BIO | KBR |
|---|---|---|
| Price | $262.80 | $36.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $358.50 | $53.14 |
| AVG Volume (30 Days) | 302.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | N/A | ★ 15.05 |
| EPS | N/A | ★ 3.21 |
| Revenue | N/A | ★ $5,767,000,000.00 |
| Revenue This Year | $2.51 | $5.79 |
| Revenue Next Year | $3.17 | $4.55 |
| P/E Ratio | ★ $9.72 | $11.46 |
| Revenue Growth | N/A | ★ 2.27 |
| 52 Week Low | $211.43 | $36.71 |
| 52 Week High | $343.12 | $56.78 |
| Indicator | BIO | KBR |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 27.66 |
| Support Level | $239.33 | N/A |
| Resistance Level | $264.68 | $43.85 |
| Average True Range (ATR) | 7.79 | 1.28 |
| MACD | -0.22 | -0.45 |
| Stochastic Oscillator | 12.17 | 2.87 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.